Key facts
- It has raised $11.4M across 2 recorded rounds; the latest was Seed Round ($1.8M) in Dec 2024.
- Medvanta has filed 2 Form Ds with the SEC since 2022, most recently Dec 2024 ($1.8M sold to 27 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Medvanta
Funding rounds
2 roundsAbout Medvanta
Developer of a healthcare platform designed to integrate, connect, and offer services for medical practices, employers, insurance providers, and patients, and transform musculoskeletal (MSK) health. The company's platform offers value-based care, marketing and communications, therapy management services, human resources, and technology services, helping clients with compliance, care navigation, and wellness programs
- Sector
- Healthcare
- HQ
- Bethesda, MD, United States
- Founded
- 2022
- Employees
- 101
- Website
- medvanta.com/
- Ownership
- Privately Held (backing)
Medvanta doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medvanta shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medvanta in its N-PORT filings yet. We sweep new filings monthly.